Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/8296
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRAUS, Jef-
dc.contributor.authorSTINISSEN, Piet-
dc.date.accessioned2008-05-23T07:37:06Z-
dc.date.available2008-05-23T07:37:06Z-
dc.date.issued2001-
dc.identifier.citationTRENDS IN IMMUNOLOGY, 22(12). p. 702-702-
dc.identifier.issn1471-4906-
dc.identifier.urihttp://hdl.handle.net/1942/8296-
dc.description.abstractIn the October issue, pp. 539–540, Table 1 of the article T-cell vaccination: from basics to the clinic by V. Kumar et al. omitted to mention an important phase II, placebo-controlled trial presently underway in Belgium (Jef Raus and Piet Stinissen). In contrast to the other trials mentioned in the table, which use peripheral-blood T cells, this trial uses T cells isolated directly from the cerebrospinal fluid of the multiple sclerosis patients in the trial. The authors would like to apologize for this omission.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.titleT-cell vaccination: from basics to the clinic (vol 22, pg 539, 2001)-
dc.typeJournal Contribution-
dc.identifier.epage702-
dc.identifier.issue12-
dc.identifier.spage702-
dc.identifier.volume22-
local.format.pages1-
local.bibliographicCitation.jcatM-
local.type.refereedRefereed-
local.type.specifiedCorrection, Addition-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.doi10.1016/S1471-4906(01)02143-3-
dc.identifier.isi000172555100011-
item.fulltextNo Fulltext-
item.contributorRAUS, Jef-
item.contributorSTINISSEN, Piet-
item.fullcitationRAUS, Jef & STINISSEN, Piet (2001) T-cell vaccination: from basics to the clinic (vol 22, pg 539, 2001). In: TRENDS IN IMMUNOLOGY, 22(12). p. 702-702.-
item.accessRightsClosed Access-
crisitem.journal.issn1471-4906-
crisitem.journal.eissn1471-4981-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.